Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2015 07:45 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Receives New York State Licensure for FHACT(R) Cervical Cancer Test

RUTHERFORD, N.J., April 16, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today that its...
April 01, 2015 08:25 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Increases Access to Its Comprehensive Cancer Diagnostic Tests & Services Through Agreement With America's Choice Provider Network(R)

CGI's full range of oncology focused testing services will be available to an additional 19 million individuals in the US RUTHERFORD, N.J., April 1, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics,...
March 23, 2015 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Present Results From Three Major Clinical Research Collaborations at USCAP Showcasing the Importance of Genomic Panels for Cancer Identification and Management

Collaborations with Keck School of Medicine of USC, University of Alabama School of Medicine, and Westchester Medical Center at New York Medical College provide insight into the diagnosis and...
March 12, 2015 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Record Fourth Quarter and Full-Year 2014 Revenue

Fourth Quarter Revenues up 118 Percent Year over Year to $4 million Full-Year 2014 Revenue Increase up 54 Percent over 2013 to $10.2 Million Cancer Genetics to Host Conference Call Today,...
February 26, 2015 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 12

RUTHERFORD, N.J., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, announced today that it will report fourth quarter and...
February 24, 2015 07:45 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Inc to Present New Data on Identification of Genomic Changes That Predict Both Metastasis and Site of Metastasis in Kidney Cancer at the 2015 ASCO Genitourinary Cancers Symposium

> CGI's genomic signature, developed in a research collaboration with Memorial Sloan-Kettering, predicts metastasis for clear-cell renal cell carcinoma (ccRCC) > Clear cell renal cell...
February 17, 2015 07:45 ET | Source: Cancer Genetics, Inc.

Cancer Genetics' Unique, Next Generation Sequencing Panel for Chronic Lymphocytic Leukemia (CLL) Selected for Use in Global Clinical Trial by Leading Biotechnology Company

CGI's unique next generation sequencing (NGS) panel, Focus::CLLTM, will be used to assess genetic aberrations and mutations that are clinically relevant and validated for CLL, the most common...
February 12, 2015 16:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Participate in the BTIG Second Annual Snowbird Medical Technology, Diagnostics & Healthcare IT Conference

RUTHERFORD, N.J., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"), an emerging leader in DNA-based cancer diagnostics, announced today that CEO and...
February 11, 2015 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Appoints Randy Goodman, Ph.D., as Director of Reimbursement and Clinical Revenue Cycle Management

RUTHERFORD, N.J., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"), an emerging leader in DNA-based cancer diagnostics, announced today the appointment of...
February 05, 2015 08:51 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Selected to Power Molecular and Biomarker Testing for Six Clinical Trials With Leading Biotech Companies Focused on Hematological Cancers

Cancer Genetics, Inc. will provide comprehensive biomarker testing, genomic analysis and molecular information for clinical trials in multiple hematological cancers. The total value of the...